GELSTAT CORP

Overview

Compare with another stock.

• TickerGSAC on OTC¹
• IndustryPharmaceutical Preparations¹
• HeadquartersMiami, Florida¹
• Incorporated inDE²
• Business address333 Se 2Nd Avenue, Suite 2000, Miami, Fl 33131²

See how the biggest companies compare on our leaderboards

Leadership

Who has led GELSTAT CORP, and when. Pick a name to see everywhere that person has worked.

• Chief executive officerJavier G. Acosta Mar 4, 2022 to Mar 4, 2022³
• Chief executive officerGerald N. Kieft Ii. Sep 26, 2008 to May 13, 2010⁴
• Chief executive officerRichard W. Ringold Aug 16, 2006 to Nov 15, 2006⁵
• PresidentRichard W. Ringold Jan 5, 2006 to Jan 5, 2006⁶

Former names

• DEVELOPED TECHNOLOGY RESOURCE INCJun 14, 1996 to Jul 15, 2003²

Timeline

1. Mar 4, 2022New chief executive Javier G. Acosta becomes CEO³
2. Sep 26, 2008New chief executive Gerald N. Kieft Ii. becomes CEO⁴
3. Aug 16, 2006New chief executive Richard W. Ringold becomes CEO⁵

Filings

20 filings to the SEC since October 2021: 2 insider forms, 18 other. The latest 20:

1. May 11, 20261-Z EDGAR
2. Apr 30, 20261-U EDGAR
3. Sep 29, 20251-SA EDGAR
4. Apr 29, 20251-K EDGAR
5. Sep 26, 20241-SA SEMI ANNUAL REPORT EDGAR
6. May 7, 20241-K EDGAR
7. Nov 28, 20231-U EDGAR
8. Oct 12, 20231-SA SEMI ANNUAL REPORT EDGAR
9. May 10, 20231-K EDGAR
10. Oct 7, 20221-U CURRENT REPORT EDGAR
11. Oct 3, 20221-SA SEMI ANNUAL REPORT EDGAR
12. May 2, 20221-K EDGAR
13. Mar 8, 20224 EDGAR
14. Mar 4, 20223 EDGAR
15. Dec 17, 2021QUALIF EDGAR
16. Dec 15, 2021CORRESP EDGAR
17. Dec 15, 20211-A/A EDGAR
18. Nov 24, 20211-A/A EDGAR
19. Nov 5, 2021UPLOAD EDGAR
20. Oct 29, 20211-A EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

1 open-market trades by officers, directors and large owners since October 2021: 1 buys and 0 sales. Grants, option exercises and gifts are left out.

From Forms 4 filed with the SEC.

SEC filer profile

How GELSTAT CORP is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

• Name on EDGARGELSTAT CORP¹
• CIK0000890725
• Employer ID (EIN)90-0075732¹
• Incorporated inDelaware¹
• Fiscal year endsDecember 31¹
• Industry code (SIC)2834 Pharmaceutical Preparations¹
• SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance¹
• Business address333 Se 2Nd Avenue, Suite 2000, Miami, FL 33131¹
• Phone772-212-1368¹
• On EDGAR sinceJun 14, 1996¹
• Filings190 in all: 10QSB (32), 8-K (26), 4 (25), 3 (15), NT 10-Q (10), 10-Q (9), 10KSB (8), NT 10-K (7)¹
  All 35 form types

  DEF 14A (6), 1-K (4), 1-SA (4), 10-K (4), 8-K/A (4), SC 13D (4), 1-U (3), S-8 (3), UPLOAD (3), 1-A/A (2), 10-K/A (2), 10QSB/A (2), ARS (2), SC 13D/A (2), 1-A (1), 1-Z (1), 10KSB40 (1), 15-12G (1), 4/A (1), 5 (1), CORRESP (1), DEFA14A (1), NTN 10Q (1), PRE 14A (1), QUALIF (1), REGDEX (1), REGDEX/A (1)

• Latest filingsAnnual report (10-K) Oct 22, 2012
  Quarterly report (10-Q) Oct 22, 2012
  Proxy statement (DEF 14A) Jul 12, 2004
  Latest 8-K (8-K) May 2, 2007